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Abstract
The European Commission asked EFSA for an opinion on the safety for the target animals, consumer,
user and the environment and on the efﬁcacy of a L-lysine monohydrochloride (HCl, minimum 98.5%)
and of a concentrated liquid L-lysine (base, minimum 50%) produced by a genetically modiﬁed strain
of Corynebacterium glutamicum (NRRL B-50775). They are intended to be used in feed or water for
drinking for all animal species and categories. Neither the production strain C. glutamicum NRRL
B-50775 nor its recombinant DNA was detected in the ﬁnal product. Therefore, the product does not
pose any safety concern associated with the genetic modiﬁcation of the production strain. L-Lysine HCl
and concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775 are considered safe
for the target species, for the consumer and for the environment. L-Lysine HCl produced by
C. glutamicum NRRL B-50775 is considered not irritant to skin or eyes and not a skin sensitiser. In the
absence of data, the FEEDAP Panel cannot conclude on the potential toxicity by inhalation of L-lysine
HCl produced by C. glutamicum NRRL B-50775. Concentrated liquid L-lysine (base) produced by
C. glutamicum NRRL B-50775, due to its high pH (11) it is anticipated to be corrosive to skin and eyes
and poses a risk by inhalation. L-Lysine HCl and concentrated liquid L-lysine (base) produced by
C. glutamicum NRRL B-50775 are considered as efﬁcacious sources of the essential amino acid L-lysine
for non-ruminant animal species. For the supplemental L-lysine to be as efﬁcacious in ruminants as in
non-ruminant species, it would require protection against degradation in the rumen.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of L-lysine monohydrochloride and concentrated liquid L-lysine (base) produced by fermentation
using a genetically modiﬁed Corynebacterium glutamicum strain (NRRL B-50775) for all animal species.
L-Lysine is an essential amino acid for all animal species. L-Lysine and its salts are widely used in the
feed industry to optimise dietary protein.
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L-lysine
monohydrochloride (HCl) and concentrated liquid L-lysine (base) was in line with the principles laid
down in Regulation (EC) No 429/2008 and the relevant EFSA guidance documents. The FEEDAP
Panel used the data provided by the applicant together with data from other sources, to deliver the
present output.
Neither the production strain C. glutamicum NRRL B-50775 nor its recombinant DNA was detected
in the ﬁnal product. Therefore, the product does not pose any safety concern associated with the
genetic modiﬁcation of the production strain.
L-Lysine HCl and concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775 are
considered safe for the target species, for the consumer and for the environment.
L-Lysine HCl produced by C. glutamicum NRRL B-50775 is considered not irritant to skin or eyes and
not a skin sensitiser. In the absence of data, the FEEDAP Panel cannot conclude on the potential
toxicity by inhalation of L-lysine HCl produced by C. glutamicum NRRL B-50775.
Concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775, due to its high pH
(11) it is anticipated to be corrosive to skin and eyes and poses a risk by inhalation.
L-Lysine HCl and concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775 are
considered as efﬁcacious sources of the essential amino acid L-lysine for non-ruminant animal species.
For the supplemental L-lysine to be as efﬁcacious in ruminants as in non-ruminant species, it would
require protection against degradation in the rumen.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Archer Daniels Midland Company (ADM)2 for
authorisation of the product L-lysine monohydrochloride and concentrated liquid L-lysine (base), when
used as a feed additive for all animal species (category: Nutritional additives; functional group: Amino
Acids, their salts and analogues).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 28 July 2017.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product L-lysine monohydrochloride and concentrated liquid L-lysine, when used under the proposed
conditions of use (see Section 3.1.3).
1.2. Additional information
The active substance of the two products under application, L-lysine, is produced by a genetically
modiﬁed strain of Corynebacterium glutamicum (NRRL B-50775).
L-Lysine is currently authorised for its use in all animal species as a nutritional additive.3 No
maximum content in feedingstuffs is established in the European Union (EU). L-Lysine and L-lysine
acetate are authorised for speciﬁc nutritional purposes in foods for particular nutritional uses.4 L-Lysine
and its hydrochloride salt may be used in the manufacture of infant formulae and follow-on formulae
in order to satisfy requirements on amino acids and other nitrogen compounds.5 Lysine hydrochloride
is described in the European Pharmacopoeia (2016) monograph 01/2008:0930. Lysine is listed as
pharmacologically active substance in veterinary medicinal products and is not subject to maximum
residue limits when used in food-producing animals.6
The Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) has published
several opinions on the safety and efﬁcacy of L-lysine: some of them on L-lysine sulphate produced by
fermentation using different strains of C. glutamicum for all animal species (EFSA FEEDAP Panel, 2007,
2015a,b, 2016b) or using a strain of Escherichia coli (EFSA FEEDAP Panel, 2017) and others on the
safety and efﬁcacy of concentrated liquid L-lysine (base), concentrated liquid L-lysine monohydrochloride
and/or L-lysine monohydrochloride for all animal species (EFSA FEEDAP Panel, 2013, 2014, 2015b,
2016a), produced by fermentation using different strains of E. coli or C. glutamicum (EFSA FEEDAP
Panel, 2016b).
The Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food (AFC)
issued an opinion on L-lysine and its monohydrochloride salt when used as a ﬂavouring compound
(EFSA, 2008a,b, 2010). The Panel on Dietetic Products, Nutrition and Allergies (NDA) issued three
opinions on the substantiation of health claims related to L-lysine (EFSA NDA Panel, 2011a,b, 2014).
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF) issued an
opinion on consideration of 88 ﬂavouring substances considered by EFSA for which EU production
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 ADM Speciality Ingredients (Europe) B.V. Kingsfordweg 43-117, 1043 GP Amsterdam, the Netherlands.
3 Commission Directive 88/485/EEC of 26 July 1988 amending the Annex to Council Directive 82/471/EEC concerning certain
products used in animal nutrition. OJ L 239, 30.8.88, pp. 36–39.
4 Commission Regulation (EC) No 953/2009 of 13 October 2009 on substances that may be added for speciﬁc nutritional
purposes in foods for particular nutritional uses. OJ L 269, 14.10.2009, pp. 9–19.
5 Commission Regulation (EC) No 1243/2008 of 12 December 2008 amending Annexes III and VI to Directive 2006/141/EC as
regards compositional requirements for certain infant formulae. OJ L 335, 25, 13.12.2008, p. 18.
6 Commission Regulation (EU) No 37/2010, of 22 December 2009 on pharmacologically active substances and their classiﬁcation
regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, pp. 72.
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volumes/anticipated production volumes have been submitted on request by DG SANCO, including
L-lysine (FLAVIS No. 17.026) as a ﬂavouring compound (EFSA, 2011b)
Bacterial protein from C. glutamicum as well as by-products from the production of amino acids
with C. glutamicum (the cells of the microorganisms have to be inactivated or killed) are listed in the
Catalogue of feed materials (Commission Regulation (EU) 68/2013).7 C. glutamicum is regarded as
qualiﬁed presumption of safety (QPS) only when used as a production organism for amino acids,
provided the susceptibility to antimicrobials has been demonstrated (EFSA, 2007; EFSA BIOHAZ Panel,
2013, 2017).
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier8 in support of the authorisation request for the use of L-lysine HCl and concentrated liquid
L-lysine as a feed additive. The technical dossier was prepared following the provisions of Article 7 of
Regulation (EC) No 1831/2003, Regulation (EC) No 429/20089 and the applicable EFSA guidance
documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA to deliver the present output.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of L-lysine monohydrochloride and concentrated liquid L-lysine produced
by C. glutamicum NRRL B-50775 in animal feed. The Executive Summary of the EURL report can be
found in Annex A.10
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of L-lysine HCl
and concentrated liquid L-lysine is in line with the principles laid down in Regulation (EC) No 429/2008
and the relevant guidance documents: Guidance on nutritional additives (EFSA FEEDAP Panel, 2012a),
Technical guidance: Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011),
Technical Guidance for assessing the safety of feed additives for the environment (EFSA, 2008a,b),
Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b),
Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP
Panel, 2012c), Technical Guidance: Microbial Studies (EFSA, 2008a,b), Guidance on the assessment of
bacterial susceptibility to antimicrobials of human and veterinary importance (EFSA FEEDAP Panel,
2012d) and Guidance on the risk assessment of genetically modiﬁed microorganisms and their
products intended for food and feed use (EFSA GMO Panel, 2011).
3. Assessment
The product subject of this application is L-lysine in the forms of monohydrochloride (HCl) or
concentrated liquid L-lysine (base) produced by fermentation with a genetically modiﬁed strain
C. glutamicum. L-Lysine is currently authorised for use as a nutritional additive, under the functional
group ‘amino acids, their salts and analogues’. The product under application is intended to be used in
feed and water for drinking for all animal species and categories.
3.1. Characterisation
3.1.1. Characterisation of the production microorganism
The two forms of the additive are produced by a genetically modiﬁed strain of C. glutamicum,
which is deposited in the US Agricultural Research Service Patent Culture Collection as C. glutamicum
7 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials. OJ L 29/1, 30.1.2013, pp. 1–64.
8 FEED dossier reference: FAD-2017-0024.
9 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
10 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep_fad-2017-0024_lysine.pdf
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NRRL B-50775.11 C. glutamicum is a Gram-positive, non-pathogenic bacterium, which has been
recommended for QPS when used for the production of amino acids (EFSA BIOHAZ Panel, 2013,
2017).
3.1.1.1. Information relating to the genetically modiﬁed microorganism
The production strain, C. glutamicum NRRL B-50775, was obtained from the strain
12
Characteristics of the recipient or parental microorganism
The recipient strain, was developed from
The strain is reported to be susceptible to the antibiotics listed in the technical guidance
for the assessment of bacterial antimicrobial susceptibility (EFSA FEEDAP Panel, 2012d) to ‘Other Gram
+’, except to kanamycin.13 The identity of the recipient strain was conﬁrmed as
C. glutamicum 14
Characterisation of the donor organism
15
16
Description of the genetic modiﬁcation process
3.1.2. Manufacturing process
L-Lysine is produced by fermentation.
The applicant states that no antimicrobials, including antibiotics,
are used in the manufacturing processes of L-lysine HCl and concentrated liquid L-lysine 50%.17
3.1.3. Conditions of use
L-Lysine is proposed to be used in feeds for all animal species to achieve an adequate amino acid
proﬁle and to meet the L-lysine requirements. Both forms can be added directly to feedingstuffs or
complementary feedingstuffs. Only L-lysine HCl is proposed to be used via premixture. Both forms of
the additive can be added to water for drinking.18 Particular care should be given to an appropriate
formulation to avoid amino acids imbalances. No inclusion levels have been proposed, as the
11 Technical dossier/Section II/Annex 2.2.1.2.a.
13 Technical dossier/Section II/Annex 2.2.2.2.a.
17 Technical dossier/Section II/Annex 2.3.l 7.
18 Technical dossier/Section 2.5.1.
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requirements, in quantitative terms, depend on the species, the physiological state of the animal, the
performance level, the environmental conditions and the amino acid composition of the
unsupplemented diet.
3.1.4. Characterisation of the L-lysine monohydrochloride
L-Lysine HCl (International Union of Pure and Applied Chemistry (IUPAC) name: (2S)-2,6-
diaminohexanoic acid monohydrochloride, synonym L-lysine hydrochloride, a compound identiﬁed
with the Chemical Abstracts Service (CAS) No 657-27-2 and the European Inventory of Existing
Commercial Chemical Substances (EINECS) No 211-519-9), has a molecular weight of 182.65 g/mol.
The theoretical content of lysine in lysine monohydrochloride is 80%. The molecular formula is
NH2–(CH2)4–CH(NH2)–COOH–HCl and the molecular structure is given in Figure 1.
The speciﬁcation is for an additive containing ≥ 98.5% L-lysine HCl, ≤ 1.5% water and < 1%
unidentiﬁed material.19
The average lysine content analysed in ﬁve batches was 79.1% (range 79.0–79.2%) on an ‘as is’
basis.20 The content of chloride was on average 19.1% (range 19.0–19.3%). The water content was in
the range 0.1–0.2%. On a dry matter basis, the sum of lysine and chloride was on average 98.3%.21
Other constituents were proteins (0.11–0.16%), free amino acids other than lysine (0.06–0.1%),
sulfate (0.03–0.04%), crude fat (0.05–0.07%), and liquid chromatography–mass spectrometry (LC–MS)
identiﬁed material (0.5–0.6%).22 The amount of identiﬁed material on dry matter basis was 99.2%.
The speciﬁcation for lysine monohydrochloride is not reached.
The speciﬁc optical rotation was measured in three batches and ranged from +20.7 to + 20.8°
(reference values of the United States Pharmacopoeia range between + 20.4 and + 21.4°).23
3.1.4.1. Impurities of L-lysine HCl
Analytical data (three batches) on the content of heavy metals (lead, cadmium and mercury) and
arsenic were provided. Lead, cadmium and arsenic were < 10 lg/kg and mercury was < 0.17 lg/kg.24
Dioxins and the sum of dioxin plus dioxin-like polychlorinated biphenyls (PCBs) in three batches of the
product were < 0.14 ng (WHO, 2005) PCDD/F TEQ per kg and 0.27 ng (WHO, 2005) PCDD/F-PCB
TEQ/kg.25 Aﬂatoxins (not speciﬁed), ochratoxin A, zearalenone, a-zearalenol, b-zearalenol and zeranol,
deoxynivalenol (DON) and 3-acetyl DON were below the corresponding limit of detection (LOD).26
Fumonisins B1, B2 and B3 ranged from 560 to 583 lg/kg and citrinin from 30.5 to 35.4 lg/kg.
Microbiological contamination was analysed in ﬁve batches and showed that Salmonella spp. was
absent in 100 g. E. coli and coliforms were < 3 colony forming unit (CFU)/g. Aerobic plate count,
Pseudomonas, coagulase-positive staphylococci, yeasts and ﬁlamentous fungi were < 10 CFU/g.27
The concentrations of the aforementioned contaminants/impurities do not raise safety concerns.
Figure 1: Molecular structure of L-lysine HCl
19 Technical dossier/Section 2.1.3 and Annex 2.1.3.
20 Technical dossier/Supplementary information April 2018/Annex 1. Method of association of analytical communities (AOAC)
999.13.
21 Technical dossier/Section II/Annex 2.1.3.
22 LC/MS identiﬁed material including adenine, guanine, cytosine, thymine, uracil, valerolactam, 2.3-butanediol, N(alpha)-acetyl-
lysine, N(epsilion)-acetyl-lysine, N-acetyl-cadaverine, N,N-diacetyl-cadaverine, phenyllactic acid, polypropylene glycol, 2-
isopropylmalic acid, 2-isopropylmaleic acid, lysine dimer, hypoxanthine and aminocaprolactam.
23 Technical dossier/Supplementary information April 2018/Annex 2.
24 Technical dossier/Section II/Annex 2.1.4c.
25 Technical dossier/Section II/Annexes 2.1.4e1, f1 and g1.
26 Technical dossier/Section II/Annex 2.1.4d. LOD in µg/kg were 1.7 for aﬂatoxins, 5 for ochratoxin A, 17 for zearalenone + a-
zearalenol, b-zearalenol and zeranol, and 134 for DON + 3-ac DON.
27 Technical dossier/Section II/Annex 2.1.4a.
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No viable cells of the production strain were found in ﬁve batches of the L-lysine HCl (each tested in
triplicate).
28
No recombinant DNA was detected in three batches of L-lysine HCl
29
3.1.4.2. Physical characteristics of L-lysine monohydrochloride
The additive is a tan coloured granulate, with a water solubility of 500–600 g/L at 25°C.30 Its bulk
density (three batches) ranged from 640 to 710 kg/m3.31
Particle size distribution (three batches) was analysed by laser diffraction and the fraction of
particles < 10 lm diameter was < 1% in all three batches. The fractions of particles < 50 and
< 100 lm diameter ranged from < 1% to 1.3% and from 1.2% to 1.7%, respectively (v/v).32 Mean
particle size ranged from 586 to 716 lm. The dusting potential of these three batches (Stauber–
Heubach method) ranged from 1.7 to 3.6 g/m3.33
3.1.4.3. Stability and homogeneity
The shelf life of L-lysine HCl (three batches) was studied when stored in closed plastic bottles at 25–
30°C protected from light for 24 months. Losses ranged from 0% to 1.2%.34
The stability of the additive (three batches) in a vitamin–mineral premixture (without choline
chloride) for pigs when supplemented at 10% was studied.35 Three samples per batch were collected
in paper bags with inner plastic liner and stored at 37–40°C for 6 months. Losses ranged from 0% to
7%, depending on the batch considered.
The stability of three batches of the additive in a complete feed for pigs (mash and a pelleted, with
a basal diet containing maize and soybean meal) when supplemented at 0.5% lysine was studied.
Pelleting was performed at 82°C. Three samples per batch and feed (mash or pelleted) were collected
in paper bags as described above, stored in ambient conditions for 3 months.35 Losses in mash feed
ranged from 0% to 8% and those of pelleted feed from 0% to 3%. Loss during feed processing
(comparing average values of mash and pelleted feed at T0) was 7%.
The stability of three batches of L-lysine HCl in water for drinking was studied at ﬁve different
concentrations (0.1, 0.5, 1, 5 and 10 g/L) at 18–23°C for 3 days.36 No losses were detected.
To prove the capacity of the L-lysine HCl to distribute homogeneously in feed, the applicant
provided a homogeneity study performed with L-lysine HCl originating from a different production
strain (C. glutamicum NRRL B-50547).37 Since the physical characteristics, the purity and the
production process are similar, the FEEDAP Panel considered the previous data as representative for
the product under assessment. A pelleted feed for chicken for fattening was tested when
supplemented at 0.5% lysine.38 The coefﬁcient of variation (CV) of 10 analysed samples was 5%.
3.1.5. Characterisation of concentrated liquid L-lysine (base)
L-Lysine (IUPAC name (2S)-2,6 diaminohexanoic acid; synonym a,e-diaminocaproic acid), a
compound identiﬁed with the CAS No 56-87-1 and the EINECS No 200-294-2, has a molecular weight
of 146.2 g/mol. The molecular formula is NH2–(CH2)4–CH(NH2)–COOH. The molecular structure is
given in Figure 2.
30 Technical dossier/Section II/Annex 2.5.2a.
31 Technical dossier/Section 2.1.5.
32 Technical dossier/Section II/Annexes 2.1.4e1, e2, f1, f2, g1 and g2.
33 Technical dossier/Section II/Annex 2.1.5.
34 Technical dossier/Supplementary information April 2018/Annex 3.
35 Technical dossier/Section II/Annex 2.4.1a, b and c; supplementary information April 2018/Annex 4a.
36 Technical dossier/Supplementary information April 2018/Annex 6.
37 FAD-2010-0067/Technical dossier/Supplementary information January 2015/Annexes/Annex Q1 homogeneity Lys HCl ADM.
38 Technical dossier/Section II/Annex 2.4.2a.
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The product is speciﬁed to contain ≥ 50% lysine, ≤ 45% water and about 1% unidentiﬁed
material.19
The speciﬁcation was conﬁrmed by analytical data from ﬁve batches which contained on average
50.8% lysine as is (range 50.1–51.4%).39 The water content was 43.5% (range 43.3–43.8%). Other
relevant constituents were free amino acids other than lysine (range 0.5–0.6%), protein (without free
amino acids other than lysine, range 0.7–0.9), ash (range 0.3–0.4%), organic acids (0.3–0.4%). The
LC/MS miscellaneous fraction described above was on average 2.5% (range 2.4–2.6%).40 The amount
of lysine on dry matter basis was 89.8% (range 89.2–90.7%).
On a dry matter basis, the sum of quantiﬁed components was on average 98.3% (range 98.1–
98.9%). The amount of the active substance (L-lysine) was less than 95% on a dry matter basis.
3.1.5.1. Impurities
Analytical data of three batches of concentrated liquid L-Lysine (base) were provided. Heavy metals
(lead and cadmium) and arsenic were < 10 lg/kg and mercury was < 0.17 lg/kg.41 Dioxins and the
sum of dioxin plus dioxin-like PCBs were < 0.14 ng (WHO, 2005) PCDD/F TEQ per kg and 0.27 ng
(WHO, 2005) PCDD/F-PCB TEQ per kg (in all three batches).42 Aﬂatoxins (not speciﬁed) ranged from
below LOD to 2.1 lg/kg; ochratoxin A ranged from 41 to 44 lg/kg; zearalenone, a-zearalenol, b-
zearalenol and zeranol ranged from 329 to 361 lg/kg; DON and 3-acetyl DON were below the LOD.43
Fumonisins B1, B2 and B3 ranged from 644 to 1,299 lg/kg and citrinin from 462 to 497 lg/kg. The
microbial contamination (analysed in ﬁve batches) showed that Salmonella spp. was absent in 100 mL,
coliforms and E. coli were < 3 CFU/mL, Pseudomonas, coagulase-positive staphylococci, yeasts and
ﬁlamentous fungi were < 10 CFU/mL each.44 The amount of the aforementioned contaminants/
impurities does not raise safety concerns.
No viable cells of the production strain were found in ﬁve batches of the concentrated liquid L-lysine
(base) (each tested in triplicate).
45
No recombinant DNA was detected in three batches of concentrated liquid L-Lysine (base)
46
3.1.5.2. Physical characteristics of concentrated liquid L-lysine (base)
Concentrated liquid L-lysine (base) is an aqueous solution of dark brown colour with a viscosity at
20°C ranging from 69 to 125 mm2/s (three batches analysed), a density at 20°C ranging from 1,140 to
1,150 kg/m3 (three batches analysed).47 It is soluble in water and has a boiling point of 115°C.48 It
has a pH (measured in three batches) of 11.49
Figure 2: Molecular structure of L-lysine
39 Analytical method: AOAC 999.13.
40 Technical dossier/Section II/Annex 2.1.3.
41 Technical dossier/Section II/Annex 2.1.4c.
42 Technical dossier/Section II/Annexes 2.1.4h1, 2.1.4h2 and 2.1.4h3.
43 Technical dossier/Section II/Annex 2.1.4d. LOD in µg/kg was 1.7 for aﬂatoxins, and 134 for DON + 3-ac DON.
44 Technical dossier/Section II/Annex 2.1.4b.
47 Technical dossier/Section II/Annexes 2.1.4h1 to 2.1.4h3.
48 Technical dossier/Section II/Annex 2.5.2b.
49 Technical dossier/Supplementary information April 2018/Annex 10.
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3.1.5.3. Stability and homogeneity
The shelf life of three batches of concentrated liquid L-lysine (base) were studied when stored in
closed plastic containers protected from light at 13°C for 12 months.50 No losses were observed. No
data were provided on stability at higher temperatures.
The stability of three batches of the additive in a complete feed for pigs (mash and a pelleted, with
a basal diet containing maize and soy meal) when supplemented at 1% with concentrated liquid
L-lysine (base) was studied. Pelleting was performed at 82°C. Three samples per batch and feed (mash
or pelleted) were collected in paper bags with inner plastic liner, stored in ambient conditions for
3 months.51 Losses in mash feed ranged from 5% to 8%; and those of pelleted feed from 3% to 8%.
No losses of lysine were observed during pelleting.
To prove the capacity of the concentrated liquid L-lysine (base) to distribute homogeneously in feed,
the applicant provided an homogeneity study performed with concentrated liquid L-lysine (base)
originating from a different production strain (C. glutamicum NRRL B-50547).52 Since the physical
characteristics, the purity and the production process are similar, the FEEDAP Panel considered the
previous data as representative for the product under assessment. A pelleted feed for chicken for
fattening was tested when supplemented at 0.19% lysine.53 The CV of 10 analysed subsamples was
4%.
The stability of three batches of liquid L-lysine (base) in water for drinking was studied at ﬁve
different concentrations (0.1, 0.5, 1, 5 and 10 g/L) at 18–23°C for 3 days.36 No losses were detected.
3.1.6. Physico-chemical incompatibilities in feed
No physico-chemical incompatibilities in feed are expected with other additives, medicinal products
or other feed materials.
3.1.7. Safety of concentrated liquid L-lysine (base) and L-lysine HCl
3.1.7.1. Safety of the genetic modiﬁcation
The recipient organism
. C. glutamicum is recommended for QPS when used for the production of amino acids
(EFSA BIOHAZ Panel, 2017).
It also contains
genes , inserted into its genome.
The presence of genes would be considered as a hazard if present in
the product. The applicant provided sufﬁcient information that neither the production strain nor its
recombinant DNA is present in the ﬁnal product. Therefore, the product L-lysine, manufactured by
fermentation with C. glutamicum NRRL B-50775, does not give rise to any safety concern with regard
to the genetic modiﬁcation of the production strain provided that the manufacturing process ensures
the absence of viable cells and recombinant DNA of the production strain in the ﬁnal products.
3.1.7.2. Safety for the target species
Lysine requirements of different non-ruminant species and animal categories, absorption and
metabolic fate of L-lysine, tolerance to L-lysine excess and the lysine to arginine antagonism have been
described in detail in previous opinions. No safety concerns for ruminants would arise from ruminal
lysine metabolism (EFSA FEEDAP Panel, 2013, 2014).
Tolerance studies with indispensable amino acids such as lysine cannot be designed according to
the protocols of conventional toxicity experiments because high dietary concentrations of a certain
amino acid will result in amino acid imbalances with depression of feed intake and hence impaired
performance. Nevertheless, for nutritional additives produced by fermentation, the risk associated with
the residues of the fermentation process in the ﬁnal product needs to be assessed.
Both products are obtained by the same genetically modiﬁed strain of C. glutamicum, a species
that qualiﬁes for the QPS approach for safety assessment when used to produce amino acids. The
50 Technical dossier/Supplementary information April 2018/Annex 3 and annex 11.
51 Technical dossier/Section II/Annex 2.4.1a, b and c.
52 FAD-2010-0067/Technical dossier/Supplementary information January 2015/Annexes/Annex Q1 homogeneity Lys base ADM.
53 Technical dossier/Section II/Annex 2.4.2b.
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identity of the strain has been established as C. glutamicum and the fermentation product would raise
no safety concerns for the target species. The strain contains genes and
this could be seen as a safety concern. However, viable cells of the production strain and their DNA
were not detected in the ﬁnal products. Consequently, the FEEDAP Panel considers that L-lysine HCl
and concentrated liquid L-lysine (base) produced by the strain C. glutamicum NRRL B-50775 do not
represent a risk for the target species.
The FEEDAP Panel reiterates its previous statement that amino acids, their salts and analogues
should generally not be used in water for drinking because of the risk of amino acid imbalances and
for hygiene reasons (EFSA, 2010).
3.1.7.3. Safety for the consumer
Absorption, distribution, metabolism and excretion of L-lysine were described in a previous scientiﬁc
opinion of the FEEDAP Panel (EFSA FEEDAP Panel, 2013). The use of the amino acid L-lysine itself in
animal nutrition is considered safe for consumers.
Both products are obtained by the same genetically modiﬁed strain of C. glutamicum, a species
that qualiﬁes for the QPS approach for safety assessment. Since the identity of the strain has been
established as C. glutamicum, the FEEDAP Panel considers that no safety concerns for the consumer
would arise from the production process. Although the production strain contains
genes, the absence of viable cells of the production strain or of its
recombinant DNA in the ﬁnal product has been demonstrated. Consequently, the FEEDAP
Panel considers that L-lysine HCl and concentrated liquid L-lysine (base) produced by the strain C.
glutamicum NRRL B-50775 do not represent a risk for the consumer.
3.1.7.4. Safety for the user
No data were submitted on the products under assessment.
L-Lysine HCl
• Effects on the respiratory system
Although the fractions of particles < 50 and < 100 lm diameter were up to 1% and 2%,
respectively (v/v), the product has high dusting potential (up to 3.6 g/m3; see section 3.1.4.2).
The applicant provided an inhalation toxicity study performed with a different product (L-lysine
sulfate) which is not further considered.54
• Effects on skin and eyes
The applicant submitted an acute dermal irritation/corrosion study (in accordance with OECD
Guideline 404), an eye irritation/corrosion study (in accordance with OECD 405) and a skin
sensitisation study (in accordance with OECD Guideline 406) where the test item was an L-lysine HCl
produced by a different production strain (C. glutamicum KCTC 12307BP). Those studies are
summarised as follows:
An acute dermal irritation/corrosion study according to OECD Guideline 404 was carried out with L-
lysine HCl (99.5% pure).55 None of the three female albino rabbits used showed dermal irritation/
corrosion at any observation time (1, 24, 48 and 72 h post-administration). Thus, the product L-lysine
HCl is classiﬁed as not irritating to human skin.
An acute eye irritation/corrosion test in accordance with OECD Guideline 405 was performed using L-
lysine HCl (99.5% pure).56 No irritation/corrosion was observed in the eyes of the tested rabbits during
the observation period. Thus the product L-lysine HCl is classiﬁed as not irritating to human eyes.
The skin sensitisation potential of the L-lysine HCl (99.5%) was studied in guinea pigs in accordance
with OECD Guideline 406 (Guinea pig maximisation test).57 No dermal reactions were observed at the
24- or 48-h post-challenge. Consequently, the test item has no sensitising properties.
As the L-lysine HCl under assessment is produced by a similar manufacturing process, it has similar
characteristics and purity compared with the L-lysine HCl produced by C. glutamicum KCTC 12307BP,
the FEEDAP Panel considers that the results of the acute dermal irritation/corrosion study, the eye
54 Technical dossier/Section III/Annex 3.3.1.1.
55 Technical dossier/Section III/Annex 3.3.1.2a.
56 Technical dossier/Section III/Annex 3.3.1.2b.
57 Technical dossier/Section III/Annex 3.3.1.2c.
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irritation/corrosion study and the skin sensitisation study mentioned above are also applicable to the
L-lysine HCl under assessment. So, L-lysine HCl produced by C. glutamicum NRRL B-50775 is
considered not irritant to skin or eyes and not a skin sensitiser. The FEEDAP Panel cannot conclude on
the potential toxicity by inhalation of L-lysine HCl produced by C. glutamicum NRRL B-50775.
Concentrated liquid L-lysine (base)
The applicant submitted an acute dermal irritation/corrosion study (in accordance with OECD
Guideline 404), an eye irritation/corrosion study (in accordance with OECD 405) and a skin
sensitisation study (in accordance with OECD Guideline 406) where the test item was a concentrated
liquid L-lysine (base) produced by a different production strain (C. glutamicum KCTC 12307BP). Those
studies are summarised as follows:
An acute dermal irritation study was performed with a concentrated liquid L-lysine (50%) in rabbits
in accordance with OECD Guideline 404.58 None of the rabbits showed any skin reaction.
Consequently, the product is classiﬁed as not irritating to human skin.
An acute eye irritation study was conducted with a concentrated liquid L-lysine (50%, pH 9.95) in
rabbits, in accordance with OECD Guideline 405.59 Some redness of conjunctiva and chemosis was
observed within 24 h post application in different grades in all three rabbits. As the recorded scores
were lower than the threshold value for classifying a product as eye irritant (0.7 vs 2), the test
material is considered not irritant for human eye.
The skin sensitisation potential of a concentrated liquid L-lysine (50%) was studied in guinea pigs in
accordance with OECD Guideline 406 (Guinea pig maximisation test).60 No dermal reactions were
observed at the 24- or 48-h post-challenge. Consequently, the test item has no sensitising properties.
The FEEDAP Panel considers that the results of the acute dermal irritation/corrosion study, the eye
irritation/corrosion study and the skin sensitisation study mentioned above cannot be extended to
concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775 because the pH of the
product under assessment is one point higher. The FEEDAP Panel considers that the product under
assessment is corrosive to skin and eyes and poses a risk by inhalation.
Conclusions on the safety for the user
L-Lysine HCl produced by C. glutamicum NRRL B-50775 is considered not irritant to skin or eyes and
not a skin sensitiser. The FEEDAP Panel cannot conclude on the potential toxicity by inhalation of L-
lysine HCl produced by C. glutamicum NRRL B-50775.
Concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775, due to its high pH
(11), is corrosive to skin and eyes and poses a risk by inhalation.
3.1.7.5. Safety for the environment
Neither viable cells of the production strain C. glutamicum NRRL B-50775 nor its recombinant DNA
were detected in the ﬁnal product. The production strain contains genes
and this could be seen as a safety concern. However, viable cells of the production strain and their
DNA were not detected in the ﬁnal products. Therefore, the products do not pose any environmental
safety concern associated with the genetic modiﬁcation of the production strain.
The amino acid L-lysine is a physiological and natural component of the proteins of living organisms.
When consumed, it will be absorbed, and the non-absorbed fraction will be incorporated into the
intestinal microbial mass and excreted as such. The absorbed L-lysine will be incorporated into body
protein or excreted as urea/uric acid and as carbon dioxide.
Consequently, the FEEDAP Panel considers that L-lysine HCl and concentrated liquid L-lysine (base)
produced by the strain C. glutamicum NRRL B-50775 do not represent a risk for the environment.
3.1.8. Efﬁcacy
Efﬁcacy studies are not required for amino acids naturally occurring in proteins of plants and
animals. The nutritional role of the amino acid L-lysine is well established in the scientiﬁc literature. In
general, the products concentrated liquid L-lysine (base) and L-lysine HCl are considered as efﬁcacious
sources of the essential amino acid L-lysine for non-ruminant animal species. For the supplemental
58 Technical dossier/Spontaneous supplementary information July 2018/Annexes 15a and 15b.
59 Technical dossier/Spontaneous supplementary information July 2018/Annex 15c.
60 Technical dossier/Spontaneous supplementary information July 2018/Annex 15d.
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L-lysine to be as efﬁcacious in ruminants as in non-ruminant species, it would require protection
against degradation in the rumen (Chalupa, 1976; Broderick and Balthrop, 1979).
3.1.9. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation61 and Good
Manufacturing Practice.
4. Conclusions
Neither the production strain C. glutamicum NRRL B-50775 nor its recombinant DNA was detected
in the ﬁnal product. Therefore, the product does not pose any safety concern associated with the
genetic modiﬁcation of the production strain.
L-Lysine HCl and concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775 are
considered safe for the target species, for the consumer and for the environment.
L-lysine HCl produced by C. glutamicum NRRL B-50775 is considered not irritant to skin or eyes and
not a skin sensitiser. In the absence of data, the FEEDAP Panel cannot conclude on the potential
toxicity by inhalation of L-lysine HCl produced by C. glutamicum NRRL B-50775.
Concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775, due to its high pH
(11) it is anticipated to be corrosive to skin and eyes and poses a risk by inhalation.
L-Lysine HCl and concentrated liquid L-lysine (base) produced by C. glutamicum NRRL B-50775 are
considered as efﬁcacious sources of the essential amino acid L-lysine for non-ruminant animal species.
For the supplemental L-lysine to be as efﬁcacious in ruminants as in non-ruminant species, it would
require protection against degradation in the rumen.
Documentation provided to EFSA
1) L-Lysine HCl and concentrated liquid L-lysine (base) produced using Corynebacterium
glutamicum for all animal species. June 2017. Submitted by ADM Speciality Ingredients
(Europe) B.V.
2) L-Lysine HCl and concentrated liquid L-lysine (base) produced using Corynebacterium
glutamicum for all animal species. Supplementary information. April 2018. Submitted by ADM
Speciality Ingredients (Europe) B.V.
3) L-Lysine HCl and concentrated liquid L-lysine (base) produced using Corynebacterium
glutamicum for all animal species. Spontaneous supplementary information. July 2018.
Submitted by ADM Speciality Ingredients (Europe) B.V.
4) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods of Analysis of L-lysine monohydrochloride and concentrated liquid L-lysine produced
by Corynebacterium glutamicum NRRL B-50775.
5) Comments from Member States.
Chronology
Date Event
16/6/2017 Dossier received by EFSA
16/6/2017 Reception mandate from the European Commission
28/7/2017 Application validated by EFSA – Start of the scientiﬁc assessment
16/11/2017 Request of supplementary information to the applicant in line with Article 8(1)(2) of Regulation
(EC) No 1831/2003 – Scientiﬁc assessment suspended. Issues: characterisation of L-lysine HCl and
concentrated liquid L-lysine (base), stability and safety for the user.
27/10/2017 Reception of the Evaluation report of the European Union Reference Laboratory for Feed
Additives
28/10/2017 Comments received from Member States
20/04/2018 Reception of supplementary information from the applicant - Scientiﬁc assessment re-started
61 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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Date Event
4/7/2018 Spontaneous submission of information by the applicant. Issues: safety for the user
28/11/2018 Opinion adopted by the FEEDAP Panel. End of the Scientiﬁc assessment
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Abbreviations
AFC EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in contact with Food
CAS Chemical Abstracts Service
CEF EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CFU colony forming unit
CG chemical group
CV coefﬁcient of variation
DM dry matter
DON deoxynivalenol
EINECS European Inventory of Existing Commercial Chemical Substances
EURL European Union Reference Laboratory
FCC Food Chemical Codex
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
FID ﬂuorescence detection
FLAVIS The EU Flavour Information System
FL-no FLAVIS number
IEC ion exchange chromatography
IUPAC International Union of Pure and Applied Chemistry
LC–MS liquid chromatography-mass spectrometry
LOD limit of detection
NDA EFSA Panel on Dietetic Products, Nutrition and Allergies
PCB polychlorinated biphenyl
PCDD/F polychlorinated dibenzo-p-dioxin/dibenzofuran
QPS qualiﬁed presumption of safety
RSDr relative standard deviation for repeatability
RSDR relative standard deviation for reproducibility
TEQ toxic equivalent
VIS visible detection
WHO World Health Organization
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Annex A – Evaluation Report on the Analytical Methods submitted in
connection with the Application for Authorisation of L-lysine
monohydrochloride and concentrated liquid L-lysine produced by
Corynebacterium glutamicum NRRL B-50775
In the current application, authorisation is sought under Article 4(1) L-lysine in the form of L-lysine
monohydrochloride and concentrated liquid L-lysine produced both by Corynebacterium glutamicum
NRRL B-50775, under the category/functional group 3(c) ‘nutritional additives’/’amino acids, their salts
and analogues’, according to Annex I of Regulation (EC) No 1831/2003. Authorisation is sought for all
animal species. L-Lysine is already authorised as feed additive under Commission Directive 88/485/EEC.
For the quantiﬁcation of lysine in the feed additive, the Applicant submitted the ring-trial validated
method EN ISO 17180:2013 based on ion exchange chromatography coupled with post-column
derivatisation and visible or ﬂuorescence detection (IEC-VIS/FD). The following performance
characteristics are reported: a relative standard deviation for repeatability (RSDr) ranging from 0.7 to
1.7%; and a relative standard deviation for reproducibility (RSDR) ranging from 1.5 to 2.5%. In
addition, the EURL identiﬁed the ‘L-lysine monohydrochloride monograph’ of the Food Chemical Codex
(FCC) for the identiﬁcation of L-lysine monohydrochloride in the feed additive.
For the quantiﬁcation of L-lysine in premixtures, feedingstuffs and water the Applicant submitted the
ring-trial validated Community method (Commission Regulation (EC) No 152/2009) based on IEC
coupled with post-column derivatisation using an amino acid analyser or high-performance liquid
chromatography with an ion exchange column and photometric detection (VIS). This method,
designed only for the analysis of premixtures and feedingstuffs, does not distinguish between the salts
and the amino acid enantiomers. The following performance characteristics were reported for the
quantiﬁcation of total lysine: RSDr ranging from 2.1 to 3.5% and RSDR ranging from 3.0 to 13.1%.
The Applicant did not perform any validation/veriﬁcation studies to demonstrate the suitability of
the Community method for the determination of lysine in water. However, in the frame of the stability
studies, the Applicant applied a slightly modiﬁed analytical method and demonstrated its applicability.
Based on the performance characteristics available, the EURL recommends for ofﬁcial control (i) the
‘L-lysine monohydrochloride monograph’ of the FCC based on infrared absorption for the identiﬁcation
of L-lysine monohydrochloride in the feed additive; (ii) the ring-trial validated method EN ISO
17180:2013 based on IEC coupled to visible or ﬂuorescence detection (IEC-VIS/FD) to quantify free
lysine in the feed additive and premixtures (containing more than 10% lysine); (iii) the Community
method based on IEC-VIS for the quantiﬁcation of lysine in premixtures and feedingstuffs; and (iv) the
modiﬁed Community method based on IEC-VIS to quantify lysine in water.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005, as last
amended by Regulation (EU) 2015/1761) is not considered necessary.
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